SCH 336

• Description :

  SCH 336 is a potent, selective, inverse and orally active CB2 agonist. SCH 336 inhibits BaF3/CB2 migration. SCH 336 significantly inhibits the migration of leukocytes in vivo. SCH 336 blocks ovalbumin-induced lung eosinophilia in mice[1].

• Product Name Alternative :

  SCH-225336

• UNSPSC :

  12352005

• Target :

  Cannabinoid Receptor

• Type :

  Reference compound

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/sch-336.html

• Concentration :

  10mM

• Purity :

  98.63

• Solubility :

  DMSO : 100 mg/mL (ultrasonic)

• Smiles :

  CS(N[C@H](C1=CC=C(C=C1)S(C2=C(C=C(C=C2)OC)S(=O)(C3=CC=C(C=C3)OC)=O)(=O)=O)C)(=O)=O

• Molecular Formula :

  C23H25NO8S3

• Molecular Weight :

  539.64

• References & Citations :

  [1]Lunn CA, et al. A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leukocyte recruitment in vivo. J Pharmacol Exp Ther. 2006 Feb;316 (2) :780-8.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  CB2

• CAS Number :

  [447459-51-0]